About
Lansion Biotechnology Co., Ltd. (Lansionbio) is a biotechnology company based in Nanjing, China, founded in 2016. It specializes in the research, development, production, and sales of in vitro diagnostic (IVD) reagents and devices. Lansionbio focuses on providing rapid detection solutions through its multi-platform point-of-care testing (POCT) workstation, catering to medical institutions and individual families. The company has developed a range of rapid diagnostic tests, contributing to the global response to the COVID-19 pandemic with CE-certified products exported to over 50 countries. Lansionbio operates a large R&D base and production workshop, supported by a team of over 150 engineers and more than 200 patents. It offers OEM, ODM, and its own brand products, emphasizing innovation, quality, and affordability in its offerings. Lansionbio is committed to improving human health worldwide with its reliable diagnostic solutions.
Technologies
Keywords
Company Information
-
Employees 56
-
Founded 2016
-
Annual Revenue $8000000
-
Total Funding $28365600
Location
5 Qiande Road, Nanjing Shi, Jiangsu Sheng, China, 211123